Developing new drugs for cancer.
نویسندگان
چکیده
منابع مشابه
Developing New Small Molecular Drugs for Prostate Cancer Therapy
Most of the early prostate cancer has no obvious symptoms, but its malignancy metastasis will cause largely deaths. The treatment options for patients with prostate cancer include traditional surgery, external beam therapy, hormone therapy, small molecular drug and cryosurgery. It was considered non-traditional treatments also can be used in alternative medicines for prostate cancer therapy. Th...
متن کاملNew drugs for breast cancer.
Recently there have been significant advances in rational drug design for the treatment of breast cancer, especially in the area of targeted drug therapy. These include drugs which target the HER2 receptor and angiogenesis and the novel class of drug the PARP inhibitors. Some of these agents, for example, trastuzumab used in the treatment of HER2 positive breast cancer are already established a...
متن کاملDeveloping drugs for developing countries.
Infectious and parasitic diseases create enormous health burdens, but because most of the people suffering from these diseases are poor, little is invested in developing treatments. We propose that developers of treatments for neglected diseases receive a "priority review voucher." The voucher could save an average of one year of U.S. Food and Drug Administration (FDA) review and be sold by the...
متن کاملDeveloping Drugs for Leukemia’s
At present, available therapies are only partially effective in patients with leukemia and the vast majority of patients cannot be cured with current treatment strategies. Hence, there is an obvious need to develop more specific and effective drugs for the treatment of these diseases. In the last twenty years, significant progress in molecular and cellular biology has resulted in a better chara...
متن کاملWhen Patents Fail: Finding New Drugs for the Developing World
Worldwide drug research budgets for diseases of poverty (e.g. malaria, African sleeping sickness) will likely double by 2010. The question is how best to spend this money. This paper analyzes the possible strategies in terms of two new categories. End-to-End (" E2E ") proposals try to mimic the patent system by using a single reward to elicit innovation throughout the entire drug discovery pipe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1991
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.303.6812.1270-a